Microinjection of interferon and 2',5'-oligoadenylate into mouse L cells and their effects on virus growth

Insights

Interferon (IFN) did not inhibit virus growth when microinjected into cells, suggesting it acts externally. However, 2

Area of Science:

  • Cell biology
  • Virology
  • Immunology

Background:

  • Interferon (IFN) is a key antiviral protein.
  • The mechanism of IFN action, particularly intracellularly, is not fully understood.
  • 2',5'-oligoadenylate (2-5A) is a second messenger involved in IFN signaling.

Purpose of the Study:

  • To investigate the intracellular antiviral effects of interferon (IFN) and 2',5'-oligoadenylate (2-5A) in mouse L cells.
  • To determine if IFN acts from outside or inside the cell.
  • To assess the dose-dependency and duration of the antiviral effect of 2-5A.

Main Methods:

  • Development of a novel microinjection apparatus for intracellular delivery.
  • Microinjection of IFN or 2-5A into mouse L cells.
  • Infection of cells with vesicular stomatitis virus (VSV) and labeling with [3H]uridine in the presence of actinomycin D.
  • Quantification of viral RNA synthesis using autoradiography.

Main Results:

  • Intracellular IFN injection showed no significant inhibition of VSV replication.
  • This suggests that IFN exerts its antiviral effect extracellularly.
  • Microinjected 2-5A effectively inhibited VSV growth in a dose-dependent manner.
  • The antiviral effect of 2-5A was transient, diminishing after 24 hours.

Conclusions:

  • IFN likely acts on the cell surface to induce antiviral states.
  • 2-5A can directly inhibit viral replication intracellularly.
  • The intracellular antiviral pathway involving 2-5A is effective but temporary.